Tag Archives: Safety

U.S., European drugmakers pledge to make safety the main focus in coronavirus vaccine development

Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards that their experimental immunizations will be held against, amid a hurried global race to contain the pandemic. The companies, including Pfizer, GlaxoSmithKline and AstraZeneca, in a joint statement made a “historic pledge… to uphold the integrity of the scientific process as… Read More »

Coronavirus: Randox recalls up to 750,000 test kits over safety concerns

Up to 750,000 unused coronavirus testing kits are being recalled due to safety concerns. The UK’s medicines and healthcare products regulator (MHRA) asked Randox to recall the kits sent out to care homes and individuals. The government said it was a “precautionary measure” and the risk to safety was low. It comes weeks after the… Read More »

Buyer beware: Groups issue toy safety warnings ahead of Black Friday

After the Thanksgiving turkey comes Black Friday holiday gift shopping, and with it warnings about how parents can avoid purchasing dangerous toys for their kids. Manufacturers have to comply with more than 100 regulations and tests by third parties before they call sell their products in the United States, according to the Toy Association. Still,… Read More »

Pediatricians are more likely to ask families about smoke alarm safety than gun safety, study says

That’s according to a new study published Monday in JAMA Pediatrics. The study found that pediatricians and pediatric residents were less likely to ask their patients about gun storage safety than smoke alarm safety — indicating an overall hesitation in bringing up gun safety with their patients. A team of doctors and researchers analyzed health… Read More »

With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst

For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »